Sheena Jonathan has filed a Form 144 to sell 108 shares of Natera, Inc.'s common stock, valued at approximately $44,744. This filing, submitted on November 2, 2026, highlights Jonathan's ongoing activity as a director of the company.

Natera, Inc. is a prominent player in the medical laboratories industry, focusing on genetic testing and related services. The company, incorporated in Delaware, operates under the SEC file number 001-37478. Its headquarters is located in Austin, Texas, where it continues to innovate in the field of medical diagnostics.

According to the filing, the shares Jonathan plans to sell were acquired through restricted stock units that vested on October 31, 2026. The filing states, "The securities to be sold were acquired upon the vesting of restricted stock units during the period of October 31, 2026 through October 31, 2026." This indicates a strategic move to liquidate a portion of her holdings in the company.

In addition to the current filing, Jonathan has been active in selling shares over the past few months. Notably, she sold 291 shares on October 27, 2026, for gross proceeds of approximately $118,146.04, and 3,150 shares on October 21, 2026, for about $1,293,245.73. These transactions suggest a pattern of liquidating stock, possibly to realize gains or for personal financial planning.

This activity may affect Natera's stock dynamics and investor sentiment, especially as the medical laboratories sector continues to evolve. Industry players are closely monitoring such transactions, as they can influence market perceptions and trading strategies.

The filing does not specify what happens next regarding Jonathan's stock sales or any potential future filings.